These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 24755011)

  • 21. Choosing covariates in the analysis of clinical trials.
    Beach ML; Meier P
    Control Clin Trials; 1989 Dec; 10(4 Suppl):161S-175S. PubMed ID: 2605965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach.
    Tsiatis AA; Davidian M; Zhang M; Lu X
    Stat Med; 2008 Oct; 27(23):4658-77. PubMed ID: 17960577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjustment for regression dilution in epidemiological regression analyses.
    Knuiman MW; Divitini ML; Buzas JS; Fitzgerald PE
    Ann Epidemiol; 1998 Jan; 8(1):56-63. PubMed ID: 9465995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of covariate adjustment at randomization and analysis for binary outcomes: understanding differences between superiority and noninferiority trials.
    Nicholas K; Yeatts SD; Zhao W; Ciolino J; Borg K; Durkalski V
    Stat Med; 2015 May; 34(11):1834-40. PubMed ID: 25641057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous covariate imbalance and conditional power for clinical trial interim analyses.
    Ciolino JD; Martin RH; Zhao W; Jauch EC; Hill MD; Palesch YY
    Contemp Clin Trials; 2014 May; 38(1):9-18. PubMed ID: 24607294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covariate adjustment for randomized controlled trials revisited.
    Wang J
    Pharm Stat; 2020 May; 19(3):255-261. PubMed ID: 31863636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomization-based adjustment of multiple treatment hazard ratios for covariates with missing data.
    Lam D; Koch GG; Preisser JS; Saville BR; Hussey MA
    J Biopharm Stat; 2017; 27(3):373-386. PubMed ID: 28281895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How large are the consequences of covariate imbalance in cluster randomized trials: a simulation study with a continuous outcome and a binary covariate at the cluster level.
    Moerbeek M; van Schie S
    BMC Med Res Methodol; 2016 Jul; 16():79. PubMed ID: 27401771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model inconsistency, illustrated by the Cox proportional hazards model.
    Ford I; Norrie J; Ahmadi S
    Stat Med; 1995 Apr; 14(8):735-46. PubMed ID: 7644855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covariate imbalance and adjustment for logistic regression analysis of clinical trial data.
    Ciolino JD; Martin RH; Zhao W; Jauch EC; Hill MD; Palesch YY
    J Biopharm Stat; 2013; 23(6):1383-402. PubMed ID: 24138438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment and implication of prognostic imbalance in randomized controlled trials with a binary outcome--a simulation study.
    Chu R; Walter SD; Guyatt G; Devereaux PJ; Walsh M; Thorlund K; Thabane L
    PLoS One; 2012; 7(5):e36677. PubMed ID: 22629322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should stroke trials adjust functional outcome for baseline prognostic factors?
    ; Gray LJ; Bath PM; Collier T
    Stroke; 2009 Mar; 40(3):888-94. PubMed ID: 19164798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should we adjust for covariates in nonlinear regression analyses of randomized trials?
    Hauck WW; Anderson S; Marcus SM
    Control Clin Trials; 1998 Jun; 19(3):249-56. PubMed ID: 9620808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving precision and power in randomized trials with a two-stage study design: Stratification using clustering method.
    Ye X; Lu N; Xu Y
    Pharm Stat; 2023 Mar; 22(2):396-407. PubMed ID: 36504179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An imbalance in cluster sizes does not lead to notable loss of power in cross-sectional, stepped-wedge cluster randomised trials with a continuous outcome.
    Kristunas CA; Smith KL; Gray LJ
    Trials; 2017 Mar; 18(1):109. PubMed ID: 28270224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjusting power for a baseline covariate in linear models.
    Glueck DH; Muller KE
    Stat Med; 2003 Aug; 22(16):2535-51. PubMed ID: 12898543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the variability of covariate adjustment. experience with Koch's method for evaluating the absolute difference in proportions in randomized clinical trials.
    Lesaffre E; Bogaerts K; Li X; Bluhmki E
    Control Clin Trials; 2002 Apr; 23(2):127-42. PubMed ID: 11943440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current issues with covariate adjustment in the analysis of data from randomized controlled trials.
    Alemayehu D
    Am J Ther; 2011; 18(2):153-7. PubMed ID: 19797942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.